Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
04/30/2014 | CN103764164A Production of dense bodies (db) from hcmv-infected cells |
04/30/2014 | CN103756669A Indole pH fluorescence probe, and preparation method and application thereof |
04/30/2014 | CN103755695A Amide compounds with antitumor activity and application of amide compounds |
04/30/2014 | CN103755686A Piperidyl substituted 5-hydroxytryptophane derivatives with anti-platelet aggregation activity |
04/30/2014 | CN103755685A Purifying and refining method of esomeprazole sodium |
04/30/2014 | CN103755684A Preparation method of baquiloprim |
04/30/2014 | CN103755683A Treatment method of bilastine reaction mother liquor |
04/30/2014 | CN103755682A Novel crystal form for desloratadine and preparation method thereof |
04/30/2014 | CN103755681A 3-(2,2,3,3-tetrafluoropropoxy)-pyrazole amide compound and application thereof |
04/30/2014 | CN103755647A C2-bit derivative of 4(3H)-quinazolinone and preparation method and application thereof |
04/30/2014 | CN103755595A Hydroxamic acid derivative and application thereof |
04/30/2014 | CN103755587A Derivatives of 4-polyfluoroalkyl-2,4-disubstituted pyrrole and preparation method thereof |
04/30/2014 | CN103254170B Pyrazole ring-containing pesticide |
04/30/2014 | CN103073535B Synthetic method of imidacloprid |
04/30/2014 | CN102797150B Halamine antibacterial agent, its preparation method and application |
04/30/2014 | CN102558157B Ethoxyl-triazole compound or amonoethyl-triazole compound and preparation method and application thereof |
04/30/2014 | CN102548558B Novel aminopyridine derivatives having Aurora A selective inhibitory action |
04/30/2014 | CN102112467B Pyrimidine derivative as kinase inhibitors |
04/30/2014 | CN101896481B Pyrimidyl indoline compound |
04/30/2014 | CN101743238B 3-(imidazolyl)-pyrazolo[3,4-b]pyridines |
04/30/2014 | CN101735797B Red phosphorescent macromolecular iridium complex electroluminescent material and preparation method thereof |
04/30/2014 | CN101668742B Bridged six-membered ring compounds |
04/30/2014 | CN101633655B Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
04/30/2014 | CN101484420B Indoles as 5-HT6 modulators |
04/29/2014 | US8710261 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
04/29/2014 | US8710232 Imidazole derivatives used as TAFIa inhibitors |
04/29/2014 | US8710229 Hepatitis C virus inhibitors |
04/29/2014 | US8710223 Protein kinase C inhibitors and uses thereof |
04/29/2014 | US8710174 Triazine ring-containing polymer and film-forming composition comprising same |
04/29/2014 | US8710084 Tetrazolyl oxime derivative, salt thereof, and plant disease control agent |
04/29/2014 | US8710082 Benzimidazole inhibition of biofilm formation |
04/29/2014 | US8710081 5-lipoxygenase-activating protein (FLAP) inhibitors |
04/29/2014 | US8710080 Prodrugs of [4 [4-(5-Aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(1H-pyrrolo-pyridin-yl)-methanones and synthesis thereof |
04/29/2014 | US8710078 Crystalline solvates of 6-(piperidin-4-yloxy)-2H-isoquinolin-1-one hydrochloride |
04/29/2014 | US8710076 2,5-disubstituted piperidine orexin receptor antagonists |
04/29/2014 | US8710062 Piperazinedione compounds |
04/29/2014 | US8710060 Piperazinyl methyl phenyl cyclohexane compound |
04/29/2014 | US8710058 Polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof |
04/29/2014 | US8710055 Triazolylphenyl sulfonamides as serine/threonine kinase inhibitors |
04/29/2014 | US8710049 Diaminocyclohexane compounds and uses thereof |
04/29/2014 | US8710043 TRPM8 antagonists and their use in treatments |
04/29/2014 | US8709513 Liquid formulations of carboxamide arthropodicides |
04/29/2014 | US8709129 Compounds useful as ligands of actinides, their synthesis and their uses |
04/29/2014 | CA2753552C N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators |
04/29/2014 | CA2734877C [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4-trifluoromethoxy-1h-indol-3-yl]-methanone as an inhibitor of mast cell tryptase |
04/29/2014 | CA2681206C 8-(heteroarylmethoxy)quinoline compounds as bradykinin b2 receptor modulators |
04/29/2014 | CA2661741C N-pyridylpiperidine compound, method for producing the same, and pest control agent |
04/29/2014 | CA2655573C Therapeutic or prophylactic agent for multiple sclerosis |
04/29/2014 | CA2637631C Pyrimidine compounds and uses thereof |
04/29/2014 | CA2573976C Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
04/29/2014 | CA2570873C Pyrimidine urea derivatives as kinase inhibitors |
04/24/2014 | WO2014062938A1 Rory modulators |
04/24/2014 | WO2014062732A1 Substituted benzene compounds |
04/24/2014 | WO2014062667A1 Phenyl linked quinolinyl modulators of ror-gamma-t |
04/24/2014 | WO2014062658A1 Methylene linked quinolinyl modulators of ror-gamma-t |
04/24/2014 | WO2014062655A1 HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt |
04/24/2014 | WO2014061991A1 Novel organic electroluminescent compounds and organic electroluminescent device containing the same |
04/24/2014 | WO2014061963A1 Organic electroluminescence compounds and organic electroluminescence device comprising the same |
04/24/2014 | WO2014061961A1 Organic electroluminescence compounds and organic electroluminescence device comprising the same |
04/24/2014 | WO2014061960A1 Compound for organic electroluminescent device, organic electroluminescent device and electronic device thereof using same |
04/24/2014 | WO2014061882A1 Diaromatic amino acid substrate for cathepsin detection |
04/24/2014 | WO2014060908A1 Improved process for preparation of revaprazan hydrochloride |
04/24/2014 | WO2014060493A2 N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone group |
04/24/2014 | WO2014060449A1 Multicomponent crystalline system comprising nilotinib and selected co-crystal formers |
04/24/2014 | WO2014060386A1 Indol-amide compounds as beta-amyloid inhbitors |
04/24/2014 | WO2014060375A2 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group |
04/24/2014 | WO2014060371A1 Inhibitors of syk |
04/24/2014 | WO2014060341A1 Substituted carbamate compounds and their use as transient receptor potential (trp) channel antagonists |
04/24/2014 | WO2014060328A1 6-aminoindole derivatives as trp channel antagonists |
04/24/2014 | WO2014059518A1 Solid forms of nilotinib hydrochloride |
04/24/2014 | WO2013162148A9 Compound for organic optoelectric device, organic light emitting device containing same, and display device containing said organic light emitting device |
04/24/2014 | WO2012116246A3 Pesticidal compostions and processes related thereto |
04/24/2014 | US20140114067 Benzimidazole derivatives as mitochondrial function modulators |
04/24/2014 | US20140114064 P38 map kinase inhibitors |
04/24/2014 | US20140113938 Pyrrole Inhibitors of S-Nitrosoglutathione Reductase |
04/24/2014 | US20140113935 N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same |
04/24/2014 | US20140113934 Heterocyclic compounds for treating helminth infections |
04/24/2014 | US20140113931 Substituted picolinamide kinase inhibitors |
04/24/2014 | US20140113907 Pyridylaminoacetic acid compound |
04/24/2014 | US20140113892 Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
04/24/2014 | US20140113891 Compounds that inhibit human DNA ligases and methods of treating cancer |
04/24/2014 | US20140113890 New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
04/23/2014 | EP2722905A1 Light emitting element material and light emitting element |
04/23/2014 | EP2722329A1 Indol-amide compounds as beta-amyloid inhbitors |
04/23/2014 | EP2721025A1 New selective ccr2 antagonists |
04/23/2014 | EP2721024A1 Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4-methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl]benzamide solubilized using organic acids |
04/23/2014 | EP2721023A1 Metalloenzyme inhibitor compounds |
04/23/2014 | EP2721022A1 Metalloenzyme inhibitor compounds |
04/23/2014 | EP2721021A1 Metalloenzyme inhibitor compounds |
04/23/2014 | EP2721020A2 Metalloenzyme inhibitor compounds |
04/23/2014 | EP2721019A1 Therapeutically active compositions and their methods of use |
04/23/2014 | EP2721008A1 Hydroxy substituted isoquinolinone derivatives |
04/23/2014 | CN103748099A Macrocyclic compounds as protein kinase inhibitors |
04/23/2014 | CN103748093A Substituted imidazopyridinyl-aminopyridine compounds |
04/23/2014 | CN103748088A Inhibitors of bruton's tyrosine kinase |
04/23/2014 | CN103748087A Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof |
04/23/2014 | CN103748086A Pyridine-and pyrazine derivatives |
04/23/2014 | CN103748079A Pyridazinone compounds and their use as DAAO inhibitors |
04/23/2014 | CN103748073A Novel soft PDE4 inhibitors |
04/23/2014 | CN103739595A Compounds and compositions as protein kinase inhibitors |